1. Home
  2. PAI vs AVXL Comparison

PAI vs AVXL Comparison

Compare PAI & AVXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Western Asset Investment Grade Income Fund Inc.

PAI

Western Asset Investment Grade Income Fund Inc.

SELL

Current Price

$11.35

Market Cap

108.0M

Sector

Finance

ML Signal

SELL

Logo Anavex Life Sciences Corp.

AVXL

Anavex Life Sciences Corp.

HOLD

Current Price

$0.74

Market Cap

115.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PAI
AVXL
Founded
1973
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Trusts Except Educational Religious and Charitable
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
108.0M
115.9M
IPO Year
N/A
2013

Fundamental Metrics

Financial Performance
Metric
PAI
AVXL
Price
$11.35
$0.74
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
22.1K
★ 1.1M
Earning Date
01-01-0001
11-27-2026
Dividend Yield
★ 4.78%
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$11.24
$0.80
52 Week High
$12.95
$5.36

Technical Indicators

Market Signals
Indicator
PAI
AVXL
Relative Strength Index (RSI) 43.19 21.28
Support Level $11.24 N/A
Resistance Level $12.35 $1.60
Average True Range (ATR) 0.08 0.10
MACD -0.01 -0.01
Stochastic Oscillator 14.81 3.82

Price Performance

Historical Comparison
PAI
AVXL

About PAI Western Asset Investment Grade Income Fund Inc.

Western Asset Investment Grade Income Fund Inc is a closed-end diversified investment company. Its primary investment objective is to seek a high level of current income, consistent with prudent investment risk, through investment in a diversified portfolio of debt securities. To a lesser extent, the fund also invests in privately placed debt securities and in certain equity securities. Capital appreciation is its secondary investment objective. The fund invests a majority of its net assets in fixed income securities that are rated in the Baa or BBB categories or above at the time of purchase by one or more Nationally Recognized Statistical Rating Organizations (NRSROs) or unrated securities of comparable quality at the time of purchase (as determined by the investment adviser).

About AVXL Anavex Life Sciences Corp.

Anavex Life Sciences Corp is a clinical stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system(CNS) diseases with high unmet need. It analyzes genomic data from clinical trials to identify biomarkers, which are used in the analysis of its clinical trials for the treatment of neurodegenerative and neurodevelopmental diseases. The company focuses on developing treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its pipeline includes ANAVEX 2-73 and ANAVEX 3-71 and several other compounds in different stages of clinical and pre-clinical development.

Share on Social Networks: